Back
Citius Oncology, Inc. Stock Predictions
Still Time to Get In: RAD Intel at $0.85/Share
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
20
CTOR
Citius Oncology, Inc.
Last Price:
$1.11
Seasonality Move:
0.9%
7 Day Trial
ALL ACCESS PASS
$
7
AI Powerhouse Raises Price - But Room Remains
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radiCitius Oncology, Inc. Stock Forecast
-
Is Citius Oncology, Inc. Stock Undervalued?The current Citius Oncology, Inc. [CTOR] share price is $1.11. The Score for CTOR is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
-
CTOR is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
Will Citius Oncology, Inc. Stock Go Up Next Year?
Data Unavailable
Citius Oncology, Inc. Stock Rating
Data Unavailable
Citius Oncology, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
52-Week Data
52-Week High:
6.19
52-Week Low:
0.55
Prediction Charts
Market Cap:
87M
Price in USD:
1.11
Volume:
2.1M
Beta:
2.70
Technical Analysis
SMA50:
1.58
SMA100:
1.71
SMA200:
1.54
52-Wk Change:
-21.28%
Stock Predictions
-
Is Citius Oncology, Inc. stock public?Yes, Citius Oncology, Inc. is a publicly traded company.
-
What is the Citius Oncology, Inc. stock quote today?The Citius Oncology, Inc. stock price is 1.11 USD today.
-
How to buy Citius Oncology, Inc. stock online?You can buy Citius Oncology, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-14 | 1.29 | 1.25 | 1.31 | 1.25 |
| Nov-17 | 1.25 | 1.22 | 1.29 | 1.20 |
| Nov-18 | 1.19 | 1.28 | 1.36 | 1.19 |
| Nov-19 | 1.30 | 1.21 | 1.31 | 1.20 |
| Nov-20 | 1.23 | 1.13 | 1.27 | 1.13 |
| Nov-21 | 1.15 | 1.13 | 1.21 | 1.07 |
| Nov-24 | 1.15 | 1.12 | 1.16 | 1.09 |
| Nov-25 | 1.10 | 1.21 | 1.25 | 1.08 |
| Nov-26 | 1.25 | 1.26 | 1.35 | 1.17 |
| Nov-28 | 1.32 | 1.37 | 1.40 | 1.29 |
| Dec-1 | 1.47 | 1.64 | 1.83 | 1.40 |
| Dec-2 | 1.63 | 1.30 | 1.63 | 1.27 |
| Dec-3 | 1.26 | 1.22 | 1.31 | 1.14 |
| Dec-4 | 1.17 | 1.11 | 1.23 | 1.07 |
Citius Oncology, Inc. Earnings
Data Unavailable
Citius Oncology, Inc. Forecast Revenue Growth
Data Unavailable
* Citius Oncology, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.